Phase
Condition
Cancer
Treatment
Glucose monitoring
Standard feedback
Glucose-based biofeedback
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
be 18 years or older
have had a diagnosis of cancer
have completed curative-intended treatment for at least 3 months (except hormonetherapy or long-term maintenance chemotherapy)
be at high-risk for type 2 diabetes based on the American Diabetes Association Type 2 Diabetes Risk Test
currently insufficiently active
capable of participating in moderate-vigorous intensity unsupervised exercise
have no current diagnosis or history of type 1 or 2 diabetes
able to speak, read, and write in English
have a smartphone with daily internet access
Exclusion
Exclusion Criteria:
currently taking oral antidiabetic agents (OADs)
current treatment with any insulin regimen other than basal insulin, e.g. prandialor pre-mixed insulin
currently pregnant
on dialysis
have self-reported health issues that limit physical activity
work overnight shifts
unwilling to use the study devices
current participation in other exercise or weight loss-related program orintervention
currently on a low-carb diet
current use of other implanted medical devices such as pacemakers
do not have a smartphone that is compatible with the Fitbit and the LibreLink apps
Study Design
Study Description
Connect with a study center
The University of Texas at Arlington
Arlington, Texas 76010
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.